Anna Kaltenboeck

Verdant Research

BIOGRAPHY

Anna Kaltenboeck is the President of Verdant Research, where she focuses on economic research and policy analysis of the US pharmaceutical market. Before founding Verdant, she served as Senior Health Advisor on the Senate Committee on Finance, leading on drug pricing issues, including Medicare negotiation.

Anna previously served as Program Director for the Drug Pricing Lab at Memorial Sloan Kettering Cancer Center, studying how reimbursement policies shape the prescription drug market, informed by a decade of consulting for life sciences and pharmaceutical companies.